Abstract
The significance of inorganic and organic forms of iodine in the evolution of plants and animals is reviewed. Iodine is one of the most electron-rich atoms in the diet of marine and terrestrial organisms, and it enters cells via iodide transporters. Iodide, which acts as a primitive electron donor through peroxidase enzymes, has an ancestral antioxidant function in all iodide-concentrating cells from primitive marine algae to more recent terrestrial vertebrates. Similarly, thyroxine and iodothyronines show antioxidant activities through deiodinase enzymes. About 500-600 million years ago, in parallel with the evolution of the primitive brain in marine animals, thyroid cells originated from the primitive gut in vertebrates, migrated, and specialized in the uptake and storage of iodo-compounds in a novel follicular “thyroidal” structure, an adaptation that enabled the transition from the iodine-rich ocean to the iodine-deficient terrestrial environment.
Keywords: Antioxidants, evolution, iodine, iodide, thyroxine, Hypoiodous acid, Hypoiodite ion, Thyroid-hormone receptors, Triiodothyronine, Thyroid hormones
Current Chemical Biology
Title: Evolutionary Significance of Iodine
Volume: 5 Issue: 3
Author(s): Sebastiano Venturi
Affiliation:
Keywords: Antioxidants, evolution, iodine, iodide, thyroxine, Hypoiodous acid, Hypoiodite ion, Thyroid-hormone receptors, Triiodothyronine, Thyroid hormones
Abstract: The significance of inorganic and organic forms of iodine in the evolution of plants and animals is reviewed. Iodine is one of the most electron-rich atoms in the diet of marine and terrestrial organisms, and it enters cells via iodide transporters. Iodide, which acts as a primitive electron donor through peroxidase enzymes, has an ancestral antioxidant function in all iodide-concentrating cells from primitive marine algae to more recent terrestrial vertebrates. Similarly, thyroxine and iodothyronines show antioxidant activities through deiodinase enzymes. About 500-600 million years ago, in parallel with the evolution of the primitive brain in marine animals, thyroid cells originated from the primitive gut in vertebrates, migrated, and specialized in the uptake and storage of iodo-compounds in a novel follicular “thyroidal” structure, an adaptation that enabled the transition from the iodine-rich ocean to the iodine-deficient terrestrial environment.
Export Options
About this article
Cite this article as:
Venturi Sebastiano, Evolutionary Significance of Iodine, Current Chemical Biology 2011; 5 (3) . https://dx.doi.org/10.2174/2212796811105030155
DOI https://dx.doi.org/10.2174/2212796811105030155 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
High-dose Vitamin D Supplementation on Type 1 Diabetes Mellitus Patients: Is there an Improvement in Glycemic Control?
Current Diabetes Reviews CDC25A and B Dual-Specificity Phosphatase Inhibitors: Potential Agents for Cancer Therapy
Current Medicinal Chemistry The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review
Current Cancer Drug Targets Interactive Effect of Combined Exposure to Active and Passive Smoking on Cardiovascular System
Recent Patents on Cardiovascular Drug Discovery Radioiodine Treatment of Differentiated Thyroid Carcinoma: The Experience at Seoul National University Hospital
Current Medical Imaging Anticancer Potential of Dietary Natural Products: A Comprehensive Review
Anti-Cancer Agents in Medicinal Chemistry Carcinogenesis and Therapeutic Strategies in Thyroid Cancer
Current Drug Targets Clinical Molecular Imaging with PET Agents Other than 18F-FDG
Current Pharmaceutical Biotechnology Hydroxamic Acids, Recent Breakthroughs in Stereoselective Synthesis and Biological Evaluations
Current Organic Synthesis Peptide Prodrugs for the Treatment of CNS Disorders: A Perspective for New Drugs
Current Medicinal Chemistry Human Serum Albumin Conjugated Biomolecules for Cancer Molecular Imaging
Current Pharmaceutical Design Tumor Targeting Using Radiolabeled Antibodies for Image-Guided Drug Delivery
Current Drug Targets Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
Current Medicinal Chemistry Bench to Bedside of CTLA-4: A Novel Immuno-Therapeutic Agent for Inflammatory Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Merging Traditional Chinese Medicine with Modern Drug Discovery Technologies to Find Novel Drugs and Functional Foods
Current Drug Discovery Technologies Boronated Compounds for Imaging Guided BNCT Applications
Anti-Cancer Agents in Medicinal Chemistry Radiopharmaceutical Chemistry with Iodine-124: A Non-Standard Radiohalogen for Positron Emission Tomography
Medicinal Chemistry Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Recent Patents on Anti-Cancer Drug Discovery Current Perspectives on the Role of Nrf2 in 5-Fluorouracil Resistance in Colorectal Cancer
Anti-Cancer Agents in Medicinal Chemistry